HOP S. TRAN CAO to Survival Rate
This is a "connection" page, showing publications HOP S. TRAN CAO has written about Survival Rate.
Connection Strength
0.989
-
CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2025 Feb; 32(2):1021-1032.
Score: 0.156
-
Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809. Ann Surg Oncol. 2024 Aug; 31(8):4837-4838.
Score: 0.150
-
National Failure of Surgical Staging for T1b Gallbladder Cancer. Ann Surg Oncol. 2019 Feb; 26(2):604-610.
Score: 0.103
-
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer. 2018 Jan 01; 124(1):74-83.
Score: 0.095
-
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg. 2014 Feb; 18(2):269-78; discussion 278.
Score: 0.072
-
Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-center Study. Ann Surg Oncol. 2025 Jun; 32(6):4374-4382.
Score: 0.040
-
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience. Ann Surg Oncol. 2025 Jun; 32(6):4352-4362.
Score: 0.040
-
Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2025 Apr; 32(4):2425-2434.
Score: 0.039
-
Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.
Score: 0.037
-
Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma. Ann Surg. 2022 03 01; 275(3):415-421.
Score: 0.032
-
Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg. 2022 04; 26(4):791-801.
Score: 0.032
-
Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. 2021 08 19; 108(8):968-975.
Score: 0.031
-
Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer. J Surg Oncol. 2021 May; 123(8):1724-1735.
Score: 0.030
-
Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.
Score: 0.030
-
Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.
Score: 0.030
-
Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
Score: 0.026
-
Management of Stage I Squamous Cell Carcinoma of the Anal Canal. JAMA Surg. 2018 03 01; 153(3):209-215.
Score: 0.024
-
Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol. 2017 Feb; 115(2):144-150.
Score: 0.022